Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Discover the crucial years to consider for retirement planning. Equip yourself with strategies for a successful retirement.
21,887 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
A Gold.com board director sold a sizable stake as bullion endured its worst week in decades. This article explains wh...
Could XRP break the $5 barrier by 2026? This article breaks down the drivers, timelines, and practical steps for inve...
Summer is here, and a new approach to drinking is forming. Young adults are rewriting the rules with intentional budg...
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
Measles poses a bigger public health risk than Ebola as the World Cup attracts millions to U.S. host cities. Official...
A family with a calling aims to relocate to Caracas to fund $10,000 monthly aid. This report breaks down the costs, c...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
As UNFI approaches its 2026 earnings call, investors want clarity on margins, growth drivers, and capital strategy. T...
Medicare's day-count cliffs push hospital costs $434 per day after day 60, rising to $868 per day after day 90. The p...
Narrowing the lens on rare earths reveals how policy shifts, EV demand, and new mines could shape USA Rare Earth's st...